Lexicon Pharmaceuticals
LXRX
LXRX
107 hedge funds and large institutions have $710M invested in Lexicon Pharmaceuticals in 2021 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 29 increasing their positions, 29 reducing their positions, and 26 closing their positions.
Holders
107
Holders Change
+1
Holders Change %
+0.94%
% of All Funds
1.88%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
29
Increased
29
Reduced
29
Closed
26
Calls
$2.58M
Puts
$1.36M
Net Calls
+$1.22M
Net Calls Change
+$437K
Top Buyers
| 1 |
1
D.E. Shaw & Co
New York
|
$17.6M |
| 2 |
2
BlackRock
New York
|
$22.9M |
| 3 |
3
Nomura Holdings
Tokyo,
Japan
|
$5.4M |
| 4 |
4
Fidelity Investments
Boston,
Massachusetts
|
$53.4M |
| 5 |
5
Two Sigma Investments
New York
|
$2.76M |
Top Sellers
| 1 |
BI
1
BVF Inc
San Francisco,
California
|
$49.3M |
| 2 |
2
Morgan Stanley
New York
|
$4.14M |
| 3 |
3
Acadian Asset Management
Boston,
Massachusetts
|
$2.71M |
| 4 |
4
Millennium Management
New York
|
$1.08M |
| 5 |
5
Renaissance Technologies
New York
|
$1.83M |
